Partners

BIL’s first acquisition was Brightwater, a market-leading recruitment consultancy founded in 1998 with offices in Dublin, Cork and Belfast. The company provides permanent, contract and executive search services to its diversified client base of SMEs, large blue-chip corporates and public sector entities. Duke financed the MBO of Brightwater in September 2018, led by industry veteran and incumbent Managing Director Barbara McGrath.

BIL completed its second acquisition in January 2020. Founded in 2006, PE Global is one of the leading Healthcare and Life Sciences Recruiters in Ireland.

Vantage Resources Limited was BIL’s most recent acquisition in October 2021. Vantage is an IT contracting and talent acquisition business that sources specialist IT professionals on medium to long term contracts to a range of major Irish organisations.

The Group has supplied glass to prominent projects such as the Shard skyscraper, London’s Olympic Park, the British Museum, the Bowes Museum, Sage Gateshead, as well as Fenwicks and Selfridges department stores.

BGC, established in 1979, is based in the Midlands and serves trade customers, architects, interior designers, construction professionals and private home owners throughout the West Midlands and beyond. Its products and services range from the supply of plain glass from stock to sophisticated processing, and it holds extensive stocks of plain glass, safety glass, fire glass and horticultural glass, available for next day delivery using its own fleet of vehicles.

Tufwell, established in the 1980s, is based in West Sussex and, with its own dedicated glass tempering facility, is a specialist glass supplier of glazed partitioning, primarily servicing the London office market. By using state-of-the-art machinery, coupled with a highly skilled workforce, Tufwell is able to compete in the demanding market of London’s commercial building sector. Many of its products and services are used to supply the architectural glazing and interiors markets, with order to delivery completed in a short period of time.

PLG, established in 1977, is based in North East England and has a state of the art processing facility which caters to the most demanding commercial glass installations including oversized and/or curved glass. Its commercial glass services include internal and external glass doors, screens, shop fronts, glass balustrades, glass staircases, glass entrances and other bespoke architectural glass installations.

LAG, established in 2013, is based in Hayes and is a premium bespoke glass processor for a wide range of glazing applications including glass walls, roof glazing, glass doors, glass floors, windows, and glass box extensions. The company’s unique service offering is its ability to make glass products with a high degree of complexity in a short amount of time and is extensively used throughout the residential building market.

Founded in 2012, the Company is headquartered in Zug, Switzerland, with 34 employees. The Company has a current product portfolio of approximately 40 available drugs and its principal market is Germany.

Fairmed and its subsidiaries produce a portfolio of high-quality generic products encompassing prescription and OTC drugs, as well as dermocosmetics and dietary supplements for many therapeutic areas.

Fairmed’s strategy to succeed in the dynamic global generics market is to focus on a broad product portfolio with cost-effective manufacturing that is subject to strict quality control. In 2019, Fairmed became majority-owned by the publicly listed company Strides Pharma Science Limited (“Strides”) to provide a platform for the distribution of Fairmed’s pharmaceutical products in the EU, post-Brexit.

Incorporated in 1990, Strides is a global pharmaceutical company with more than 3,000 employees and is headquartered in Bangalore, India. Strides has a global manufacturing footprint with eight manufacturing facilities spread across three continents with a strong footprint across 100 countries.

Duke’s financing supported a shareholder buyout which transitions equity control of the business to the current executive management team.